Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
/in Colorectal Cancer, International Publications, NSCLC /von 2005-07-21 / Cancer Immunol. Immunother. 2006 Mar;55(3):268-76Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
/in Colorectal Cancer, International Publications /von 2005-07-15 / J. Immunol. 2005 Jul;175(2):820-8Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings
/in Colorectal Cancer, International Publications /von 2005-07-07 / Oncology 2005;68(2-3):276-84Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine
/in Colorectal Cancer, International Publications /von 2005-06-01 / Cancer Res. 2005 Jun;65(11):4947-54Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
/in Colorectal Cancer, International Publications /von 2005-06-01 / Expert Rev Vaccines 2005 Jun;4(3):329-50Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
/in Colorectal Cancer, International Publications /von 2005-04-15 / Clin. Cancer Res. 2005 Apr;11(8):3017-24Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2004-04-15 / Clin. Cancer Res. 2004 Apr;10(8):2645-51Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma
/in Colorectal Cancer, Hyperthermia, International Publications /von 2003-05-13 / World J Surg 2003 Jun;27(6):640-6IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de